Meridian Wealth Management’s Transmedics TMDX Stock Holding History

Meridian Wealth Management’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,679	Closed	-$204K	–	813
2025 Q4	$204K	Buy	+1,679	New	+$211K	0.01%	721
2025 Q3	–	Sell	-1,502	Closed	-$201K	–	726
2025 Q2	$201K	Buy	+1,502	New	+$165K	0.01%	644
2024 Q4	–	Sell	-2,326	Closed	-$365K	–	664
2024 Q3	$365K	Sell	2,326 -10	-0.4%	-$1.54K	0.02%	481
2024 Q2	$352K	Buy	+2,336	New	+$280K	0.04%	216

Other funds holding TMDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Meridian Wealth Management's TMDX Position: Q1 2026 in Review

Meridian Wealth Management sold out of Transmedics (TMDX) in Q1 2026, closing a stake of 1,679 shares — an estimated $204K sold.

Meridian Wealth Management first reported a position in TMDX in Q2 2024 and held it in 4 quarters. The position peaked at $365K in Q3 2024. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

Meridian Wealth Management reported no remaining Transmedics position as of Q1 2026 after selling out during the quarter.
Meridian Wealth Management sold 1,679 Transmedics shares in Q1 2026, an estimated $204K.
Meridian Wealth Management first reported a position in Transmedics in Q2 2024 and held it in 4 quarters.
Meridian Wealth Management's Transmedics position peaked at $365K in Q3 2024.
414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Meridian Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.